Role of non-HLA genetic variants in end-stage renal disease

Tissue Antigens

Volumn 74, Issue 2, 2009, Pages 147-155

  Ranganath, P ^a   Tripathi, G ^a   Sharma, R K ^b   Sankhwar, S N ^a   Agrawal, S ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Cytokines; End stage renal disease; Inflammation; Intercellular adhesive molecules; Single nucleotide polymorphisms

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; ICAM 1 GENE; IL 4 GENE; IL 6 GENE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR NECROSIS FACTOR ALPHA GENE;

ADULT; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GENE FREQUENCY; GENOTYPE; HLA ANTIGENS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-4; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; LINKAGE (GENETICS); MALE; MIDDLE AGED; NEURAL CELL ADHESION MOLECULES; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 67650418220     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2009.01276.x     Document Type: Article

References (35)

1. Levey AS, Coresh J, Balk E et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003 : 139 : 137 47.
2. Sakhuja V, Jha V, Ghosh AK, Ahmed S, Saha TK. Chronic renal failure in India. Nephrol Dial Transplant 1994 : 9 : 871 72.
3. Vleming LJ, Bruijn JA, van Es LA. The pathogenesis of progressive renal failure. Neth J Med 1999 : 54 : 114 28.
4. Ong AC, Fine IG. Tubular-derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: implications for human renal disease progression. Am J Kidney Dis 1994 : 23 : 205 9.
5. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992 : 20 : 1 17.
6. Khazen D, Jendoubi-Ayed S, Giorgio Y et al. Adhesion molecule polymorphisms in acute renal allograft rejection. Transplant Proc 2007 : 39 : 2563 4.
7. Ficek R, Kokot F, Chudek J, Adamczak M, Ficek J, Wiecek A. Plasma concentrations of tumor necrosis factor alpha may predict the outcome of patients with acute renal failure. Kidney Blood Press Res 2006 : 29 : 203 9.
8. Paul WE. Interleukin-4: a prototypic immunoregulatory cytokine. Blood 1991 : 77 : 1859 70.
9. Muller-Steinhardt M, Hartel C, Muller B, Kirchner H, Fricke L. The interleukin-6-174 promoter polymorphism is associated with long-term kidney allograft survival. Kidney Int 2002 : 62 : 1824 70.
10. Mc Laren AJ, Marshall SE, Haldar NA et al. Adhesion molecule polymorphisms in chronic renal allograft failure. Kidney Int 1999 : 55 : 1977 82.
11. Spriewald BM, Witzke O, Wassmuth R et al. Distinct tumour necrosis factor a, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis. Ann Rheum Dis 2005 : 64 : 457 61.
12. Darrin CE, Hoffmann SC, DiMercurio BS et al. Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukins-2 and interleukins-6. Transplantation 2001 : 72 : 720 6.
13. Shu KH, Lee SH, Cheng CH, Wu MJ, Lian JD. Impact of interleukin-1 receptor antagonist and tumor necrosis factor alpha gene polymorphism on IgA nephropathy. Kidney Int 2000 : 58 : 783 9.
14. Van der Paardt M, Crusius JBA, Garcia-Gonzalez MA et al. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology 2002 : 41 : 1419 23.
15. Mann CL, Davies MB, Stevenson VL et al. Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. J Neuroimmunol 2002 : 129 : 197 204. (Pubitemid 34879089)
16. Panichi V, Maggiore U, Taccola D et al. Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients. Nephrol Dial Transplant 2004 : 19 : 1154 60.
17. Villuendas G, San Millan JL, Sancho J, Escobar-Morreale HF. The -597 G→A and -174 G→C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism. J Clin Endocrinol Metab 2002 : 87 : 1134 41.
18. Fernández-Real JM, Broch M, Vendrell J, Richart C, Ricart W. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab 2000 : 85 : 1334 9.
19. Gaudino M, Andreotti F, Zamparelli R et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation 2003 : 108 : 195 9.
20. Bennet AM, Prince JA, Fei GZ et al. Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis 2003 : 171 : 359 67.
21. Stenvinkel P, Ketteler M, Johnson RJ et al. Interleukin-10, IL-6 and TNF-a: important factors in the altered cytokine network of end-stage renal disease - the good, the bad and the ugly. Kidney Int 2005 : 67 : 1216 33.
22. Reich K, Mossner R, Konig IR, Westphal G, Ziegler A, Neumann C. Promoter polymorphisms of the genes encoding tumor necrosis factor-alpha and interleukin-1beta are associated with different subtypes of psoriasis characterized by early and late disease onset. J Invest Dermatol 2002 : 118 : 155 63.
23. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8 and DR3 alleles. J Exp Med 1993 : 177 : 557 60.
24. Vatay A, Bene L, Kovács A et al. Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease. Immunogenetics 2003 : 55 : 247 52.
25. Balakrishnan VS, Guo D, Rao M et al. Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int 2004 : 65 : 1449 60.
26. Jaber BL, Rao M, Guo D et al. Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine 2004 : 25 : 212 9.
27. Hiromura K, Kurosawa M, Yano S, Naruse T. Tubulointerstitial mast cell infiltration in glomerulonephritis. Am J Kidney Dis 1998 : 32 : 593 9.
28. Masutani K, Miyake K, Nakashima H et al. Impact of interferon-gamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients. Am J Kidney Dis 2003 : 41 : 371 9.
29. Singh RR, Saxena V, Zang S et al. Differential contributions of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis. J Immunol 2003 : 170 : 4818 25.
30. Wenzel K, Ernst M, Rohde K, Baumann G, Speer A. DNA polymorphisms in adhesion molecule gene - a new risk factor for early atherosclerosis. Hum Genet 1996 : 97 : 15 20.
31. Yang H, Vora D, Targan S, Toyada H, Beaudet A, Rotter J. Intercellular adhesion molecule 1 gene association with immunologic subset of inflammatory bowel disease. Gastroenterology 1995 : 109 : 440 8.
32. Fernandez-Reyes D, Craig A, Kyes S et al. A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum Mol Genet 1997 : 6 : 1357 60.
33. Mc Laren AJ, Marshall SE, Haldar NA et al. Adhesion molecule polymorphism in chronic renal allograft failure. Kidney Int 1999 : 55 : 1977 82.
34. Walley A, Cookson W. Investigation of an IL-4 promoter polymorphism for association with asthma and atopy. J Med Genet 1996 : 33 : 689 92.
35. Yucesoy B, Vallyathan V, Landsittel DP et al. Association of tumor necrosis factor-α and interleukin-1 gene polymorphism with silicosis. Toxicol Appl Pharmacol 2001 : 172 : 75 82. (Pubitemid 32281413)